Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 258,696 shares at $6.00 ($1.6M) on 2022-11-09, disclosed to the SEC on 2022-11-14.
Open-market sale of $1.6M CTIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 46,100 | $277K | 17.8% |
| 2 | $6.01 | 7,596 | $46K | 2.9% |
| 3 | $6.02 | 300 | $2K | 0.1% |
| 4 | $6.00 | 136,408 | $818K | 52.7% |
| 5 | $6.01 | 200 | $1K | 0.1% |
| 6 | $6.01 | 26,700 |
| $160K |
| 10.3% |
| 7 | $6.02 | 16,396 | $99K | 6.4% |
| 8 | $6.02 | 16,396 | $99K | 6.4% |
| 9 | $6.02 | 100 | $602 | 0.0% |
| 10 | $6.03 | 5,800 | $35K | 2.3% |
| 11 | $6.04 | 2,700 | $16K | 1.0% |
| Total | $6.00 avg | 258,696 | $1.6M | 100% |
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-09-14 | $1.6M | — | Filing → |